Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2014, Article ID 878397, 13 pages
Research Article

Stimulation of Neural Stem Cell Proliferation by Inhibition of Phosphodiesterase 5

1Centre for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal
2Department of Biomedical Sciences and Medicine, University of Algarve, 8005-139 Faro, Portugal
3Institute for Biotechnology and Bioengineering (IBB), Centre for Molecular and Structural Biomedicine, University of Algarve, 8005-139 Faro, Portugal

Received 4 July 2013; Revised 20 November 2013; Accepted 24 November 2013; Published 12 January 2014

Academic Editor: Su-Chun Zhang

Copyright © 2014 Ana I. Santos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The involvement of nitric oxide (NO) and cyclic GMP (cGMP) in neurogenesis has been progressively unmasked over the last decade. Phosphodiesterase 5 (PDE5) specifically degrades cGMP and is highly abundant in the mammalian brain. Inhibition of cGMP hydrolysis by blocking PDE5 is a possible strategy to enhance the first step of neurogenesis, proliferation of neural stem cells (NSC). In this work, we have studied the effect on cell proliferation of 3 inhibitors with different selectivity and potency for PDE5, T0156, sildenafil, and zaprinast, using subventricular zone-(SVZ-) derived NSC cultures. We observed that a short- (6 h) or a long-term (24 h) treatment with PDE5 inhibitors increased SVZ-derived NSC proliferation. Cell proliferation induced by PDE5 inhibitors was dependent on the activation of the mitogen-activated protein kinase (MAPK) and was abolished by inhibitors of MAPK signaling, soluble guanylyl cyclase, and protein kinase G. Moreover, sildenafil neither activated ERK1/2 nor altered levels, suggesting the involvement of pathways different from those activated by T0156 or zaprinast. In agreement with the present results, PDE5 inhibitors may be an interesting therapeutic approach for enhancing the proliferation stage of adult neurogenesis.